An Interventional, Single Arm, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of APZ2 on Wound Healing of Chronic Venous Ulcer (CVU)
Phase of Trial: Phase I/II
Latest Information Update: 16 Oct 2017
At a glance
- Drugs APZ 2 (Primary)
- Indications Varicose ulcer
- Focus Adverse reactions; First in man; Therapeutic Use
- Sponsors RHEACELL
- 25 Sep 2017 The trial has been suspended in Germany.
- 26 Jan 2017 Planned End Date changed from 1 Apr 2018 to 1 Dec 2018.
- 26 Jan 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Dec 2018.